Ozempic, Insulin Resistance, and Type 2 Diabetes: What Are We Missing? | Dr. Mariela Glandt | The Metabolic Link Ep. 98
Attend a Live Q&A with Dr. Glandt. Reigster here. What if the way we treat type 2 diabetes is fundamentally backwards? Dr. Mariela Glandt is an endocrinologist and obesity medicine specialist who spent 15 years practicing conventional medicine before concluding, in her words, that how we treat diabetes “is actually upside down.” As co-founder of OwnaHealth, she focuses on addressing the insulin resistance underlying type 2 diabetes, not only the elevated blood sugar it eventually causes. ...
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from The Metabolic Link
Metabolic Gynecology: Insulin, Inflammation, and the Uterus as an End Organ | Dr. Andréa Salcedo, DO | The Metabolic Link Ep. 103
You Asked, Ben Bikman Answered: GLP-1 Muscle Loss, Ketone Targets & Cancer Metabolism | The Metabolic Link Ep. 102
Implementation of Ketogenic and Low Carbohydrate Therapies for Metabolic Disease | Franziska Spritzler, RD, CDE | The Metabolic Link Ep. 101
Ben Bikman, PhD | Rethinking Metabolic Health: Insulin, Ketones, and What Comes Next | The Metabolic Link Ep. 100
Get summaries like this every morning.
Free AI-powered recaps of The Metabolic Link and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.